Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al. Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.
1:21-cv-01736, 1:23-cv-00554, D. Del., Judge Andrews
Experience
Pfenex Inc. v. GlaxoSmithKline Biologicals SA Pfenex Inc. v. GlaxoSmithKline Biologicals SA
IPR2019-01027, -01028, PTAB
Experience
Shire ViroPharma Inc. v. CSL Behring LLC Shire ViroPharma Inc. v. CSL Behring LLC
1:17-cv-00414, D. Del., Judges Goldberg, Thynge
Experience
Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals
2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager
Experience
Finnegan client Capsugel prevails in one of the first U.S. post-grant proceedings Finnegan client Capsugel prevails in one of the first U.S. post-grant proceedings
IPR2013-00331, PTAB, Judges Crumbley, Elluru, Green
Experience
AbbVie Inc. v. Roxane Laboratories Inc. AbbVie Inc. v. Roxane Laboratories Inc.
1:12-cv-00457, D. Del., Judges Andrews, Burke
Experience
AbbVie Inc. v. Matrix Labs AbbVie Inc. v. Matrix Labs
1:09-cv-00174, D. Del., Judge Sleet
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.